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Background 
 
Respiratory syncytial virus (RSV) infections can be asymptomatic or associated with symptoms ranging from mild cold to severe acute respiratory 
infection (SARI)1 and are responsible for substantial global morbidity in young children and elderly individuals2. To implement preventive and control 
measures and to inform vaccination strategies, it is critical to characterize the epidemiological patterns of circulating RSV. 
 
Objectives 
 
This study aimed at describing the results of RSV molecular detection in respiratory samples collected from children <15 years hospitalized with 
SARI in Milan (Italy) during four consecutive years (2014-2017) and to estimate the prevalence of RSV, the risk of infection from RSV and the 
incidence of hospitalization of RSV-positive SARI stratified by age. 
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Methods 
 
From January 1st, 2014, to December 31st, 2017, 3013 respiratory samples (2826 upper respiratory tract [URT] and 187 lower respiratory tract 
[LRT] specimens) collected from as many children <15 years hospitalized with SARI at a university hospital in Milan were analysed. After nucleic 
acids extraction, samples were tested by a multiplex real-time PCR to detect RSV3. 
SARI case definition: the standard SARI case definition is: acute respiratory infection with history of high fever or measured high fever (≥38° C) and 
cough with onset within the last 10 days and requiring hospitalization4.  
Incidence rate of hospitalization of RSV-positive SARI: incidence were calculated using the average number of population <15 years of age for 
each year of study as denominator. 
Discussion and Conclusions 
 
Accordingly to other studies1-2, RSV was detected in 19% of hospitalized SARI cases <15 years, mainly in children <1 year in which the risk of RSV 
infection was 1.5-fold higher with respect to all the other age groups. As expected1-2, circulation of RSV peaked from December to February each 
year. In this series, sampling of upper or lower respiratory tract resulted in similar RSV-positivity rate. RSV is recognized as a major cause of 
hospital admissions in young children; in this study, the highest incidence of hospitalization of children less than 15 year with RSV-positive SARI 
was 426 per 100’000 children aged <1 years. Routine molecular testing to detect RSV and epidemiological study are warranted to implement  
preventive and control measures and to drive further vaccination strategies. 
 
Results 
 
1 - Prevalence of RSV-positive SARI cases 
During the study period, 571 out of 3013 (19%) respiratory samples tested positive to RSV (Table 1). In this SARI series, RSV positivity rate 
identified in LRT samples (27/187; 14.4%) and URT samples (544/2826; 19.2%) was similar (p=0.09). The median age of RSV-positive SARI cases 
was 6.6 months (inter quartile range; 17.2 months) with a male-to-female ratio of 1:1.12. Overall, 22% (355/1613) and 19% (125/658) of children 
aged less than 1 year and those aged 1-3 years, respectively, tested positive to RSV (Table 1). Cumulatively, 62.2% (355/571) of RSV were 
identified in children <1 year (Fig. 1) and 12.3% (70/571) in children <1 month.  
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2 - Risk of infection from RSV by age-groups  
The risk of RSV infection in children aged 0-1 year 
was 1.5-fold (95% CI: 1.2-1.9) higher with respect to 
all the other age groups.  
 
3 - Incidence of hospitalization of RSV-
positive SARI 
The overall incidence of hospitalization RSV-positive 
SARI was 40.5 per 100’000 children aged <15 years 
with the highest incidence rate observed in children 
less than 1 year of age (426/100’000) (Fig. 2). 
 
4 - Temporal distribution of RSV 
RSV circulated along the entire study period with the 
highest positivity rate (59.2%; 338/571) identified 
during seasonal peaks occurring from December to 
February each year.  
Table 1. Prevalence of RSV detection in children with 
SARI by age. 
0-1 1613 355 22.0%
 2-3 658 125 19.0%
 4-6 386 55 14.2%
 7-11 210 22 10.5%
 12-15 146 14 9.6%
Total 3013 571 19.0%
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Figure 2. 
Incidence of 
hospitalization of 
RSV-positive 
SARI per 
100’000 children 
<15 years of age. 
Figure 1. 
Distribution 
of RSV-
positive 
SARI by 
age. 
